Literature DB >> 30024576

AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY.

J Jason McAnany1,2, Jason C Park1, Felix Y Chau1, Yannek I Leiderman1, Jennifer I Lim1, Norman P Blair1.   

Abstract

PURPOSE: To evaluate retinal dysfunction in diabetic patients who have mild or no nonproliferative diabetic retinopathy (DR) using the high-frequency flicker electroretinogram.
METHODS: Light-adapted flicker electroretinograms were recorded from 15 diabetic patients who have no clinically apparent retinopathy, 15 diabetic patients who have mild nonproliferative DR, and 15 nondiabetic, age-equivalent controls. Electroretinograms were elicited by full-field flicker at 2 temporal frequencies, 31.25 and 62.5 Hz, and were recorded using conventional techniques. Amplitude and timing of the flicker responses were compared among the groups and correlated with clinical characteristics including age, acuity, disease duration, and HbA1c.
RESULTS: The 31.25-Hz flicker amplitude was slightly, but nonsignificantly, smaller for subjects with no DR and mild nonproliferative DR , compared with the control group (both t < 1.38, P > 0.31); small, nonsignificant response delays for both patient groups were also observed (both t < 1.57, P > 0.12). By contrast, there were significant amplitude reductions for the 62.5-Hz flicker stimulus: mean amplitude was reduced by 32% for subjects with no DR and by 41% for subjects with mild nonproliferative DR (both t > 2.92 and P < 0.01). Response timing at 62.5 Hz did not differ significantly from control for either group (both t < 1.2 and P > 0.39). Electroretinogram amplitude and timing were not correlated significantly with clinical characteristics.
CONCLUSION: The 62.5-Hz flicker electroretinogram is useful for evaluating retinal dysfunction in diabetic patients who have mild or no DR because this response can be significantly reduced. Attenuation of the high-frequency flicker electroretinogram, which is primarily generated by bipolar cells, suggests a relatively early retinal site of neural dysfunction.

Entities:  

Year:  2019        PMID: 30024576      PMCID: PMC6335196          DOI: 10.1097/IAE.0000000000002262

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Nonlinearities in the flicker electroretinogram: A tool for studying retinal dysfunction applied to early-stage diabetic retinopathy.

Authors:  J Jason McAnany; Yi-Fan Chen; Karen Liu; Jason C Park
Journal:  Vision Res       Date:  2019-06-05       Impact factor: 1.886

2.  Contrast sensitivity is associated with outer-retina thickness in early-stage diabetic retinopathy.

Authors:  J Jason McAnany; Jason C Park; Karen Liu; Michelle Liu; Yi-Fan Chen; Felix Y Chau; Jennifer I Lim
Journal:  Acta Ophthalmol       Date:  2019-09-13       Impact factor: 3.761

3.  Electrophysiological measures of dysfunction in early-stage diabetic retinopathy: No correlation between cone phototransduction and oscillatory potential abnormalities.

Authors:  J Jason McAnany; Karen Liu; Jason C Park
Journal:  Doc Ophthalmol       Date:  2019-09-11       Impact factor: 2.379

4.  Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy.

Authors:  Jason C Park; Felix Y Chau; Jennifer I Lim; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2019-04-23       Impact factor: 2.379

Review 5.  Clinical electroretinography in diabetic retinopathy: a review.

Authors:  J Jason McAnany; Oksana S Persidina; Jason C Park
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

6.  Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

7.  Temporal Frequency Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Electroretinography.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

Review 8.  Preventing diabetic retinopathy by mitigating subretinal space oxidative stress in vivo.

Authors:  Bruce A Berkowitz
Journal:  Vis Neurosci       Date:  2020-06-15       Impact factor: 3.241

9.  Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy.

Authors:  Cara T Motz; Kyle C Chesler; Rachael S Allen; Katie L Bales; Lukas M Mees; Andrew J Feola; April Y Maa; Darin E Olson; Peter M Thule; P Michael Iuvone; Andrew M Hendrick; Machelle T Pardue
Journal:  Diabetes       Date:  2020-02-12       Impact factor: 9.461

10.  Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of Prediabetes.

Authors:  Bright Asare-Bediako; Sunil K Noothi; Sergio Li Calzi; Baskaran Athmanathan; Cristiano P Vieira; Yvonne Adu-Agyeiwaah; Mariana Dupont; Bryce A Jones; Xiaoxin X Wang; Dibyendu Chakraborty; Moshe Levi; Prabhakara R Nagareddy; Maria B Grant
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.